Non-Invasive Neurally Adjusted Ventilatory Assist (NAVA) Prone vs Supine in Premature Infants

NCT05968586 — Not applicable, Completed, 30 participants, Milton S. Hershey Medical Center

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Effect of Body Position on Oxygenation, Ventilation, and Diaphragmatic Workload in Premature Infants on Non-Invasive Neurally Adjusted Ventilatory Assist (NAVA)

RegistryNCT05968586
StatusCompleted
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, treatment
Enrollment30 (Actual)
SponsorMilton S. Hershey Medical Center (Other)
ConditionsNeonatal Oxygen Desaturation, Premature, Ventilator Lung; Newborn, Apnea of Prematurity
InterventionsBody positioning (Other)
Datesstart 2023-09-11, primary completion 2024-12-28, completion 2024-12-31, first posted 2023-08-01, last updated 2025-01-29
Locations1 site in United States

Related Papers Related Patents Related Grants Related Experts
All trials for Neonatal Oxygen Desaturation All trials for Premature All trials of Body positioning

-Summary

This research study is being done to investigate the effect of changing an infant's body position on how hard the baby works to breathe, the baby's oxygen level, the baby's carbon dioxide level, the baby's lung volume, the baby's lung compliance (ability of the lung to expand and fill with air), and how frequently the baby develops clinically significant events such as apnea (baby stops breathing on his own), bradycardia (low heart rate), and desaturation (low oxygen) events.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Prone positioningExperimentalOther: Body positioning
Supine positioningActive comparatorOther: Body positioning
  • Body positioning (Other): Body positioning of infants prone vs supine.

+Outcome measures

Primary outcomes

  • Peak electrical activity of the diaphragm (Edi peaks) [From enrollment in study to end of study (a total of twelve hours)]: Height of Edi signal in uV
  • Minimum electrical activity of the diaphragm (Edi mins) [From enrollment in study to end of study (a total of twelve hours)]: Lowest of Edi signal in uV
  • Number of apenic events [From enrollment in study to end of study (a total of twelve hours)]: Number of times where infant ceases to breath for >5 seconds
  • Number of bradycardia events [From enrollment in study to end of study (a total of twelve hours)]: Number of times where infant's heart rate drops <100bpm sustained for >5s
  • Number of desaturation events [From enrollment in study to end of study (a total of twelve hours)]: Number of times where infant's oxygen saturation drops <85% sustained for >5s

+Eligibility

Sex: All, ages: 1 Minute to 3 Months

Inclusion Criteria:

* Viable infants born at ≤32 weeks of gestation on non-invasive NAVA.
* Infant must be stable on NAVA for at least 24 hours prior to the study

Exclusion Criteria:

* Infants with congenital heart disease (CHD)
* Infants with persistent pulmonary hypertension (PPHN)
* Infants with contraindications to using NAVA (e.g. neuromuscular blockage or paralysis, absent electrical signal from the diaphragm, esophageal tears or bleeding, cardiac pacemakers) or infants in whom an NG/OG catheter cannot be placed.

+Locations (1)

FacilityCityCountryStatus
Penn State Health Milton S Hershey Medical CenterHershey, PennsylvaniaUnited States

+Investigators